These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32410515)

  • 1. Optimized diagnosis of
    Cho JH; Jin SY
    Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):553-564. PubMed ID: 32410515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric randomised study of
    Leja M; Park JY; Murillo R; Liepniece-Karele I; Isajevs S; Kikuste I; Rudzite D; Krike P; Parshutin S; Polaka I; Kirsners A; Santare D; Folkmanis V; Daugule I; Plummer M; Herrero R
    BMJ Open; 2017 Aug; 7(8):e016999. PubMed ID: 28801429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population based Helicobacter pylori screening and eradication: advances versus side effects.
    Tepes B
    Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metachronous gastric cancer after successful Helicobacter pylori eradication.
    Shiotani A; Haruma K; Graham DY
    World J Gastroenterol; 2014 Sep; 20(33):11552-9. PubMed ID: 25206262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of factors associated with recovery of the serum pepsinogen ratio after
    Cho JH; Jeon SR; Jin SY; Park S
    Scand J Gastroenterol; 2019 Nov; 54(11):1306-1314. PubMed ID: 31702966
    [No Abstract]   [Full Text] [Related]  

  • 9. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
    Suzuki H; Mori H
    J Gastroenterol; 2018 Mar; 53(3):354-361. PubMed ID: 29138921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
    Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
    Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
    Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Kowada A
    Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
    Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
    Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
    Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands.
    Chiang TH; Maeda M; Yamada H; Chan CC; Chen SL; Chiu SY; Chen YN; Chou YH; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Lin MW; Wu MS; Lin JT; Chen HH; Ushijima T; Graham DY; Lee YC
    J Gastroenterol Hepatol; 2021 Mar; 36(3):671-679. PubMed ID: 32671873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.
    Asaka M; Mabe K; Matsushima R; Tsuda M
    Gastroenterol Clin North Am; 2015 Sep; 44(3):639-48. PubMed ID: 26314673
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
    Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.